Longevity Health Inc. (XAGE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Longevity Health Inc.

    NASDAQ: XAGE · Real-Time Price · USD
    2.54
    -0.07 (-2.68%)
    At close: Sep 10, 2025, 10:59 AM

    Longevity Health Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 50.32K n/a n/a n/a
    Cost of Revenue
    		 6.36K 124.79K 242.56K n/a
    Gross Profit
    		 43.96K -124.79K -242.56K n/a
    Operating Income
    		 -5M -5.22M -5.51M -467.43K
    Interest Income
    		 n/a n/a 2.25M 8.09K
    Pretax Income
    		 -10.75M -16.21M -9.05M -329.38K
    Net Income
    		 -10.37M -15.45M -9.05M -6.48M
    Selling & General & Admin
    		 3.9M 2.6M 3.22M 863.33K
    Research & Development
    		 1.05M 2.5M 2.2M 982.84K
    Other Expenses
    		 83.49K n/a -148.26K 94.16K
    Operating Expenses
    		 5.04M 5.09M 5.27M 1.94M
    Interest Expense
    		 49.02K 889.32K 3.75M 2.5M
    Selling & Marketing Expenses
    		 189.32K n/a n/a n/a
    Cost & Expenses
    		 5.05M 5.22M 5.51M 1.94M
    Income Tax Expense
    		 -97.28K n/a n/a n/a
    Shares Outstanding (Basic)
    		 20.91M 20.77M 19.77M 19.77M
    Shares Outstanding (Diluted)
    		 20.91M 20.77M 19.77M 19.77M
    EPS (Basic)
    		 -0.5 -0.74 -0.5 -0.01
    EPS (Diluted)
    		 -0.5 -0.74 -0.5 -0.01
    EBITDA
    		 -10.5M -15.19M -5.06M -329.38K
    EBIT
    		 -10.7M -15.32M -5.3M -329.38K
    Depreciation & Amortization
    		 197.26K 124.79K 242.56K 242.12K

    Add to Watchlist